| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |